Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

(2017) Bruce Neal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection FractionCLINICAL PERSPECTIVE

(2016) Søren L. Kristensen et al.   Circulation-Heart Failure

Treatment of diabetes and heart failure: joint forces

(2016) Karl Swedberg et al.   EUROPEAN HEART JOURNAL

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME®trial

(2016) David Fitchett et al.   EUROPEAN HEART JOURNAL

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

(2016) Tonje Thorvaldsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure

(2016) Isabelle Johansson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes

(2015) Petar M. Seferović et al.   EUROPEAN HEART JOURNAL

Association between type-2 diabetes mellitus and post-discharge outcomes in heart failure patients: Findings from the RICA registry

(2014) Francisco Javier Carrasco-Sánchez et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Molecular mechanisms of diabetic cardiomyopathy

(2014) Heiko Bugger et al.   DIABETOLOGIA

Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study

(2013) M. Lind et al.   DIABETOLOGIA

Is the prognosis in patients with diabetes and heart failure a matter of unsatisfactory management? An observational study from the Swedish Heart Failure Registry

(2013) Isabelle Johansson et al.   EUROPEAN JOURNAL OF HEART FAILURE

Prevalence and Prognostic Implications of Pre-Diabetic State in Patients With Heart Failure

(2011) Yuya Matsue et al.   CIRCULATION JOURNAL

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

(2011)   EUROPEAN HEART JOURNAL

Diabetes: a driver for heart failure

(2011) A. A. Voors et al.   HEART

Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus: Is It Really the First Marker of Diabetic Cardiomyopathy?

(2011) Laura Ernande et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction

(2010) Amil M. Shah et al.   EUROPEAN JOURNAL OF HEART FAILURE

Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis

(2010) Michael Egstrup et al.   EUROPEAN JOURNAL OF HEART FAILURE

Heart failure registry: a valuable tool for improving the management of patients with heart failure

(2009) Åsa Jonsson et al.   EUROPEAN JOURNAL OF HEART FAILURE

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme

(2008) M. R. MacDonald et al.   EUROPEAN HEART JOURNAL

Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study

(2007) C. Tribouilloy et al.   EUROPEAN HEART JOURNAL